The Biden administration plans to urge citizens to get booster shots for the COVID XBB.1.5 subvariant this autumn to counter a new wave.
Moderna
The WHO and the U.S. Centers for Disease Control and Prevention are tracking a new, highly mutated BA.2.86 COVID variant.
Moderna Inc has entered a licensing deal with Generation Bio Co to develop treatments targeting the immune system and liver, the latest such transaction by the vaccine maker as it expands beyond its COVID shots. Generation Bio’s shares rose about 13.14% to $4.40 in premarket trading on Thursday. Moderna will pay $40 million in cash […]
Moderna Inc said on Monday it plans to develop and begin testing vaccines targeting 15 of the world’s most worrisome pathogens by 2025 and will permanently wave its COVID-19 vaccine patents for shots intended for certain low- and middle-income countries. The U.S. biotechnology company also said it will make its messenger RNA (mRNA) technology available […]
Moderna Inc on Thursday projected higher vaccine sales for the second half of the year as it sees COVID-19 becoming a flu-like endemic illness, prompting people to take regular shots. The company expects $19 billion in sales of its vaccine this year from $18.5 billion previously and said talks were ongoing for vaccine orders in […]
Moderna Inc said on Tuesday it had begun a late-stage study of its vaccine for Respiratory Syncytial Virus (RSV) based on the same technology used to develop its COVID-19 shots. The only approved product using messenger RNA (mRNA)is COVID-19 vaccine, but Moderna and rival Pfizer are rushing to tap the potential of the technology to […]